Abstract
The search for new biopharmaceuticals is mobilizing academic, industrial and governmental sectors in the development of biotechnological processes that enable the production on an industrial scale of active principles that act against a certain disorder and minimize its side effects, as is the case of the antileukemic biopharmaceutical L-asparaginase. Acute Lymphoblastic Leukemia (ALL) is…